Monitoring the inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma

The complexity of type 2 and non-type 2 asthma requires monitoring with multiple biomarkers. We evaluated the potential of multidimensional endotyping to characterise physio-pathological clusters based on asthma severity and intensity of the blood eosinophilia.

http://ift.tt/2z0ptzW